GL1X · GenesisL1 explorer

Research workbench

Co-crystal structures of chikv NSP3 macrodomain with pyrimidone fragments

Analyse Co-crystal structures of chikv NSP3 macrodomain with pyrimidone fragments in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6W8Q
Type
protein
Length
642 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nonstructural polyprotein
UniProt
A0A4D6GPC4
Ligands
TJS
Pockets
9 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 38% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, CNonstructural polyproteinprotein16038% helix, 20% strandA0A4D6GPC4
DNonstructural polyproteinprotein16238% helix, 20% strandA0A4D6GPC4

Ligands and binding sites

  • TJS · 2-oxo-1,2,5,6,7,8-hexahydroquinazoline-4-carboxylic acid · ligand · 4 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15610.690.7858TJS
24410.660.7849TJS
32580.620.8032TJS
42130.580.8030TJS
52890.570.7744empty

Interfaces

5 interfaces between chains.

  • B–C · 589 Ų buried · 11 hydrogen bonds · protein-protein
  • A–B · 449 Ų buried · 8 hydrogen bonds · protein-protein
  • B–D · 418 Ų buried · 6 hydrogen bonds · protein-protein
  • A–D · 246 Ų buried · 2 hydrogen bonds · protein-protein
  • A–C · 11 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 6W8Q · Co-crystal structures of CHIKV nsP3 macrodomain with pyrimidone fragments · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.